Metformina (Polish Wikipedia)

Analysis of information sources in references of the Wikipedia article "Metformina" in Polish language version.

refsWebsite
Global rank Polish rank
2nd place
6th place
4th place
7th place
4,294th place
205th place
924th place
75th place
low place
624th place
719th place
1,030th place
8,738th place
165th place

doi.org

dx.doi.org

  • Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group, „The Lancet”, 352 (9131), 1998, s. 854–865, DOI10.1016/S0140-6736(98)07037-8, PMID9742977 (ang.).
  • Marzena Grzybowska, Joanna Bober, Maria Olszewska, Metformina – mechanizmy działania i zastosowanie w terapii cukrzycy typu 2, „Postępy Higieny i Medycyny Doświadczalnej”, 65, 2011, s. 277–285, DOI10.5604/17322693.941655.
  • Michael Mark, Sulfonylharnstoffe und Glinide: Vom Chemotherapeutikum zum Antidiabetikum, „Pharmazie in unserer Zeit”, 31 (3), 2002, s. 252–262, DOI10.1002/1615-1003(200205)31:3<252::AID-PAUZ252>3.0.CO;2-P (niem.).
  • Alejandro Martin-Montalvo i inni, Metformin improves healthspan and lifespan in mice, „Nature Communications”, 4, 2013, DOI10.1038/ncomms3192, PMID23900241, PMCIDPMC3736576 (ang.).
  • Lucydalila Cedillo i inni, Ether lipid biosynthesis promotes lifespan extension and enables diverse pro-longevity paradigms in Caenorhabditis elegans, „eLife”, 12, 2023, DOI10.7554/eLife.82210, PMID37606250, PMCIDPMC10444025 [dostęp 2024-01-24] (ang.).
  • Anna Markowska i inni, Could there be a role for the antidiabetic drug metformin in oncological treatment?, „European Journal of Gynecological Oncology”, 39 (6), 2018, s. 867–870, DOI10.12892/ejgo4677.2018 (ang.).
  • Josie M.M. Evans i inni, Metformin and reduced risk of cancer in diabetic patients, „British Medical Journal”, 330 (7503), 2005, s. 1304–1305, DOI10.1136/bmj.38415.708634.F7 (ang.).
  • Heather A. Hirsch i inni, Metformin selectively targets cancer stem cells, and acts together with chemotherapy to block tumor growth and prolong remission, „Cancer Research”, 69 (19), 2009, s. 7507–7511, DOI10.1158/0008-5472.CAN-09-2994, PMID19752085, PMCIDPMC2756324 (ang.).
  • Gijs W.D. Landman i inni, Metformin associated with lower cancer mortality in type 2 diabetes: ZODIAC-16, „Diabetes Care”, 33 (2), 2010, s. 322–326, DOI10.2337/dc09-1380, PMID19918015, PMCIDPMC2809274 (ang.).
  • Jared M. Campbell i inni, Metformin reduces all-cause mortality and diseases of ageing independent of its effect on diabetes control: A systematic review and meta-analysis, „Ageing Research Reviews”, 40, 2017, s. 31–44, DOI10.1016/j.arr.2017.08.003 (ang.).
  • James McCormack, Kevin Johns, Hugh Tildesley, Metformin’s contraindications should be contraindicated, „Canadian Medical Association Journal”, 173 (5), 2005, s. 502–504, DOI10.1503/cmaj.045292, PMID16129871, PMCIDPMC1188187 (ang.).
  • A. Holstein, M. Stumvoll, Contraindications can damage your health-is metformin a case in point?, „Diabetologia”, 48 (12), 2005, s. 2454–5459, DOI10.1007/s00125-005-0026-1, PMID16283245 (ang.).
  • Jolien de Jager i inni, Long term treatment with metformin in patients with type 2 diabetes and risk of vitamin B-12 deficiency: randomised placebo controlled trial, „British Medical Journal”, 340, 2010, c2181, DOI10.1136/bmj.c2181, PMID20488910, PMCIDPMC2874129 (ang.).

drugbank.ca

medscape.com

mp.pl

indeks.mp.pl

  • Metformina, [w:] Indeks Leków MP, opis substancji, Medycyna Praktyczna.

nih.gov

ncbi.nlm.nih.gov

  • Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group, „The Lancet”, 352 (9131), 1998, s. 854–865, DOI10.1016/S0140-6736(98)07037-8, PMID9742977 (ang.).
  • Alejandro Martin-Montalvo i inni, Metformin improves healthspan and lifespan in mice, „Nature Communications”, 4, 2013, DOI10.1038/ncomms3192, PMID23900241, PMCIDPMC3736576 (ang.).
  • Lucydalila Cedillo i inni, Ether lipid biosynthesis promotes lifespan extension and enables diverse pro-longevity paradigms in Caenorhabditis elegans, „eLife”, 12, 2023, DOI10.7554/eLife.82210, PMID37606250, PMCIDPMC10444025 [dostęp 2024-01-24] (ang.).
  • Heather A. Hirsch i inni, Metformin selectively targets cancer stem cells, and acts together with chemotherapy to block tumor growth and prolong remission, „Cancer Research”, 69 (19), 2009, s. 7507–7511, DOI10.1158/0008-5472.CAN-09-2994, PMID19752085, PMCIDPMC2756324 (ang.).
  • Gijs W.D. Landman i inni, Metformin associated with lower cancer mortality in type 2 diabetes: ZODIAC-16, „Diabetes Care”, 33 (2), 2010, s. 322–326, DOI10.2337/dc09-1380, PMID19918015, PMCIDPMC2809274 (ang.).
  • James McCormack, Kevin Johns, Hugh Tildesley, Metformin’s contraindications should be contraindicated, „Canadian Medical Association Journal”, 173 (5), 2005, s. 502–504, DOI10.1503/cmaj.045292, PMID16129871, PMCIDPMC1188187 (ang.).
  • A. Holstein, M. Stumvoll, Contraindications can damage your health-is metformin a case in point?, „Diabetologia”, 48 (12), 2005, s. 2454–5459, DOI10.1007/s00125-005-0026-1, PMID16283245 (ang.).
  • Jolien de Jager i inni, Long term treatment with metformin in patients with type 2 diabetes and risk of vitamin B-12 deficiency: randomised placebo controlled trial, „British Medical Journal”, 340, 2010, c2181, DOI10.1136/bmj.c2181, PMID20488910, PMCIDPMC2874129 (ang.).

pubchem.ncbi.nlm.nih.gov

sigmaaldrich.com

termedia.pl